0.45 (2.29%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Weak
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Neutral
Balance Sheet
Strong
Website
Kailera Therapeutics, Inc.
Telephone
1.781.317.0290
Address
4th floor, 180 Third Avenue, Waltham, MA 02451
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 19.01 - 28.23
Trade Value (12mth)
US$612,913.00
1 week
-6.75%
1 month
-22.2%
YTD
-24.54%
1 year
0%
All time high
28.23
EPS 3 yr Growth
N/A
EBITDA Margin
0.00%
Operating Cashflow
-$120m
Free Cash Flow Return
-29.40%
ROIC
-36.50%
Interest Coverage
0.00
Quick Ratio
12.00
Shares Outstanding (Fully Diluted)
85m
HALO Sector
Healthcare
Next Company Report Date
03-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | N/A | -2.6 | -1.76 | | | | ||
EPS (Fully Diluted) | $ | | | | | N/A | -2.6 | -1.76 | | | | ||
Growth | % | | | | | N/A | N/A | 32.2 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
